Turning foes to friends: targeting cancer-associated fibroblasts

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature reviews. Drug discovery

• Publication date

  2018-10-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41573-018-0004-1PMID 30470818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells

  2018cited by this paper
• CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.

  2018cited by this paper
• Targeting the IL-6/JAK/STAT3 signalling axis in cancer

  2018cited by this paper
• Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

  2018cited by this paper
• Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice

  2018cited by this paper
• TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

  2018cited by this paper
• Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.

  2018cited by this paper
• Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death

  2017cited by this paper
• A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion

  2017cited by this paper
• Classifying the evolutionary and ecological features of neoplasms

  2017cited by this paper
• Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.

  2017cited by this paper
• Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer

  2017cited by this paper
• Microenvironmental regulation of tumour angiogenesis

  2017cited by this paper
• Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma

  2017cited by this paper
• Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.

  2017cited by this paper
• Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.

  2017cited by this paper
• Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.

  2017cited by this paper
• Tumour radiosensitivity is associated with immune activation in solid tumours.

  2017cited by this paper
• Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

  2017cited by this paper
• Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane

  2017cited by this paper
• Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts

  2016cited by this paper
• Structure and Function of a Prostate Cancer Dissemination–Permissive Extracellular Matrix

  2016cited by this paper
• The biology and function of fibroblasts in cancer

  2016cited by this paper
• Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

  2016cited by this paper
• IL‐6 Secreted from Cancer‐Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial‐Mesenchymal Transition Signaling

  2016cited by this paper
• Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

  2016cited by this paper
• sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

  2016cited by this paper
• CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS

  2016cited by this paper
• Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion

  2016cited by this paper
• Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer

  2016cited by this paper
• A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice

  2016cited by this paper
• Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

  2016cited by this paper
• Next Generation

  2016cited by this paper
• FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.

  2016cited by this paper
• Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma

  2016cited by this paper
• Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial.

  2016cited by this paper
• Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets

  2016cited by this paper
• Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development

  2016cited by this paper
• Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression

  2016cited by this paper
• Regulation of pancreatic cancer aggressiveness by stromal stiffening

  2016cited by this paper
• Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.

  2016cited by this paper
• 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

  2016cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

  2015cited by this paper
• Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

  2015cited by this paper
• EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

  2015cited by this paper
• Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance

  2015cited by this paper
• Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

  2015cited by this paper
• Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.

  2015cited by this paper
• AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer

  2015cited by this paper
• Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts

  2015cited by this paper
• Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

  2015cited by this paper
• Is there new hope for therapeutic matrix metalloproteinase inhibition?

  2014cited by this paper
• Prognostic relevance of cancer-associated fibroblasts in human cancer.

  2014cited by this paper
• Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.

  2014cited by this paper
• Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.

  2014cited by this paper
• Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.

  2014cited by this paper
• Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent

  2014cited by this paper
• Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

  2014cited by this paper
• The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression

  2014cited by this paper
• A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

  2014cited by this paper
• The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy.

  2014cited by this paper
• Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer

  2014cited by this paper
• Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

  2014cited by this paper
• Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

  2014cited by this paper
• Sonic hedgehog signaling in Basal cell nevus syndrome.

  2014cited by this paper
• Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.

  2014cited by this paper
• Remodelling the extracellular matrix in development and disease

  2014cited by this paper
• Fibroblast heterogeneity in the cancer wound

  2014cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts

  2013cited by this paper
• Hepatic stellate cells in liver development, regeneration, and cancer.

  2013cited by this paper
• Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

  2013cited by this paper
• STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.

  2013cited by this paper
• Exosomes in tumor microenvironment influence cancer progression and metastasis

  2013cited by this paper
• Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

  2013cited by this paper
• Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens.

  2013cited by this paper
• Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

  2013cited by this paper
• Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling

  2013cited by this paper
• CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

  2013cited by this paper
• Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts

  2013cited by this paper
• Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

  2013cited by this paper
• Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1

  2013cited by this paper
• Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.

  2013cited by this paper
• Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia

  2013cited by this paper
• Abstract 1287: Epigenetic deregulation of breast cancer is associated with DNA Repair Capacity.

  2013cited by this paper
• Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis

  2013cited by this paper
• Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

  2013cited by this paper
• RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

  2012cited by this paper
• Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury

  2012cited by this paper
• Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.

  2012cited by this paper
• Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

  2012cited by this paper
• Mechanisms of fibrosis: therapeutic translation for fibrotic disease

  2012cited by this paper
• Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

  2012cited by this paper
• Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion

  2012cited by this paper
• The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.

  2012cited by this paper
• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

  2012cited by this paper
• Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production

  2012cited by this paper
• Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts

  2012cited by this paper
• p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts

  2012cited by this paper

• Epithelial-mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities.

  2026cites this paper
• Single-cell transcriptomics identifies fibroblast associated immune heterogeneity and prognostic signatures in bladder cancer

  2026cites this paper
• HOMER3 as a prognostic and immune-related biomarker in pan-cancer and esophageal carcinoma: Insights from bioinformatics and functional validation.

  2026cites this paper
• Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver.

  2026cites this paper
• Mechanical Microenvironment in Tumor Immune Evasion: Bidirectional Regulation Between Matrix Stiffness and Immune Cells and Its Therapeutic Implications

  2026influential citation
• Taming the Tumor Stroma: A Two-Stage Targeted Nanocapsule for Potent Deep Chemo-Immunotherapy in Triple-Negative Breast Cancer.

  2026cites this paper
• Drug resistance-driven cytokine alterations in the immunosuppressive microenvironment of colorectal cancer

  2026cites this paper
• Preclinical evaluation of novel 177Lu-labeled fibroblast activation protein inhibitor with albumin binder for radioligand therapy.

  2026cites this paper
• Decoding the metabolic-immune axis for novel therapeutics in bladder cancer.

  2026cites this paper
• The role of growth hormone in metastasis and angiogenesis of breast cancer.

  2026cites this paper
• POSTN⁺ cancer-associated fibroblast–CCL3⁺ macrophage crosstalk defines the immune-excluded tumor microenvironment in clear cell renal cell carcinoma

  2026cites this paper
• GLRX5 is a prognostic marker in bladder cancer and correlates with activation of cancer-associated fibroblasts in the tumor microenvironment.

  2026cites this paper
• CAT‐BLAST: Engineered bacteria for robust targeting and elimination of cancer‐associated fibroblasts

  2026cites this paper
• The Role of Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment and Their Impact on Ovarian Cancer Survival and Therapy

  2026cites this paper
• Bacteria-targeted dual-lock delivery for closed-loop immune modulation in colorectal cancer.

  2026cites this paper
• A novel tumor-progressing fibroblast signature derived from single-cell RNA sequencing enables prognostic stratification and reveals RNF11 as a functional regulator in bladder cancer

  2026cites this paper
• Tumor-Associated Neutrophils and Desmoplastic Reaction in the Breast Cancer Tumor Microenvironment: A Comprehensive Review

  2026cites this paper
• Targeting Lipid Metabolism in CAFs: A Therapeutic Opportunity in Solid Tumors.

  2026cites this paper
• Cancer-Associated fibroblasts regulate the development of cholangiocarcinoma through IL-6/STAT3/AKR1C3 signaling axis.

  2026cites this paper
• Reshaping the colorectal cancer immune microenvironment: insights from single-cell and spatial omics.

  2026cites this paper
• Cancer-associated fibroblast-derived exosomal LINC00930 represses cell malignancy and glycolysis by recruiting MBNL1 and elevating PRKAA2 stability in colorectal cancer.

  2026cites this paper
• CAF-enriched COL4A6 promotes gastric cancer progression and stromal remodeling despite an inverse association in bulk transcriptomes.

  2026cites this paper
• Integrated regulation of ferroptosis in prostate cancer covering mechanisms, resistance, and translational opportunities

  2026cites this paper
• Cancer-associated fibroblasts: enablers of tumor drug resistance

  2026cites this paper
• Identification and validation of a refined CAF-Associated diagnostic signature in breast cancer

  2026cites this paper
• Cadmium-induced activation of inflammatory cancer-associated fibroblasts-like cells enhances malignant phenotypes of lung cancer cells.

  2026cites this paper
• Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

  2026cites this paper
• Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy

  2026cites this paper
• Carvacrol Selectively Induces Mitochondria-Related Apoptotic Signaling in Primary Breast Cancer-Associated Fibroblasts

  2026cites this paper
• CDKN2AIPNL: a potential pan-cancer biomarker

  2026cites this paper
• Molecular and cellular remodeling of the colorectal tumor microenvironment using nanoparticles

  2026cites this paper
• A Pt (IV)/losartan/immunotherapy Co-delivery thermosensitive gel synergizes STING activation and cancer-associated fibroblast inhibition for ovarian cancer chemoimmunotherapy.

  2026cites this paper
• Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection

  2026cites this paper
• Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity.

  2026cites this paper
• Senescent cancer-associated fibroblasts in cancer progression: From formation to therapeutic opportunities.

  2026cites this paper
• Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

  2026cites this paper
• Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy

  2026cites this paper
• POSTN+ fibroblast-secreted small extracellular vesicles drive macrophage M2 polarization through BMP4/BMPR2/Smad signaling

  2026cites this paper
• Augmenting cuproptosis and anti-metastatic immunity in breast cancer by copper-based nanoplatform for synergistic immunotherapy via lactate metabolic reprogramming and hypoxia alleviation.

  2026cites this paper
• Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer.

  2026cites this paper
• Targeting focal adhesion kinase: From molecular mechanisms to next-generation cancer therapeutics

  2026cites this paper
• Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

  2026cites this paper
• Tumor Responsive Nanoplatforms for TME Modulation: From Extracellular Matrix to Intracellular Organelles

  2026cites this paper
• Repurposing COX-2 Inhibitors for Cancer Therapy: Advances in Nanomedicine Delivery

  2026cites this paper
• Stromal reprogramming-primed nanofiber enhances immune activation for melanoma suppression

  2026cites this paper
• RECK attenuates CAF-mediated promotion of epithelial-mesenchymal transition in breast cancer.

  2026cites this paper
• Differentiation grade and combined positive score correlation in head and neck squamous cell carcinoma.

  2026cites this paper
• Decoding the Cellular Heterogeneity and Malignant Progression of Human Penile Squamous Cell Carcinoma by Single‐Cell RNA Sequencing

  2026cites this paper
• Role of LncRNA UCA1 in OSCC CAFs: PD-L1 Upregulation and Tumor Progression.

  2025cites this paper
• TPX2 promotes papillary renal cell carcinoma progression by forming a ceRNA with LINC00894

  2025cites this paper
• Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches

  2025cites this paper
• Cancer-associated fibroblasts as a potential novel liquid biopsy marker in cancer patients

  2025cites this paper
• Revisiting the role of cancer-associated fibroblasts in tumor microenvironment

  2025cites this paper
• Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases

  2025cites this paper
• Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies

  2025cites this paper
• The roles of immune cells and non-immune cells in Pre-Metastatic Niche of Breast Cancer.

  2025cites this paper
• Construction of targeting GPR77+CD10+ lipid nanoparticles and validation of targeting capability in vitro and in vivo

  2025cites this paper
• Thyroid hormone receptor interacting protein 13 is associated with prognosis and immunotherapy efficacy in human cancers: a pan-cancer analysis

  2025cites this paper
• Pan-cancer analysis reveals immunological and prognostic significance of CCT5 in human tumors

  2025cites this paper
• Exosomes derived from ccRCC cells confers fibroblasts activation to foster tumor progression through Warburg effect by downregulating PANK3

  2025cites this paper
• The regulatory role of m6A in cancer metastasis

  2025cites this paper
• A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein

  2025cites this paper
• Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer

  2025cites this paper
• Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts

  2025cites this paper
• A pan-cancer analysis targeting the oncogenic role of ATP-binding cassette transporter A1 in human tumors

  2025cites this paper
• The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis

  2025cites this paper
• Development and evaluation of 18F-labeled novel radiopharmaceuticals for PET imaging of fibroblast activation protein expressing tumors.

  2025cites this paper
• CXCL12 alone is enough to Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts

  2025cites this paper
• The transcriptional regulators GATA6 and TET1 regulate the TGF-β pathway in cancer-associated fibroblasts to promote breast cancer progression

  2025cites this paper
• p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in Fibroblasts

  2025cites this paper
• Cancer-associated fibroblasts: multidimensional players in liver cancer

  2025cites this paper
• FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

  2025cites this paper
• Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics

  2025cites this paper
• Transforming Cancer Therapy: Unlocking the Potential of Targeting Vascular and Stromal Cells in the Tumor Microenvironment

  2025cites this paper
• Cancer-Associated Fibroblasts as the “Architect” of the Lung Cancer Immune Microenvironment: Multidimensional Roles and Synergistic Regulation with Radiotherapy

  2025cites this paper
• Role of EFNAs in Shaping the Tumor Immune Microenvironment and Their Impact on Pancreatic Adenocarcinoma Prognosis

  2025cites this paper
• Compound K-enriched Korean red ginseng prevents lung cancer progression by targeting cancer cells and fibroblasts

  2025cites this paper
• Comprehensive Metabolite Profiling in Single-Cell Systems via Dual-Modal MALDI-Mass Spectrometry Imaging.

  2025cites this paper
• Tissue‐Microenvironment‐Responsive Self‐Assembling Peptide Nanoshells Boost Pirfenidone Efficacy in the Treatment of Liver Fibrosis

  2025cites this paper
• Two Targets, One Mission: Heterobivalent Metal‐Based Radiopharmaceuticals for Prostate Cancer Imaging and Therapy

  2025cites this paper
• Targeting myofibroblastic cancer-associated fibroblasts (myCAFs): a promising strategy for overcoming tumor progression and immunotherapy resistance

  2025cites this paper
• The role of tumor-associated fibroblast-derived exosomes in chemotherapy resistance of colorectal cancer and its application prospect.

  2025cites this paper
• Self-supervised learning enables unbiased patient characterization from multiplexed cancer tissue microscopy images

  2025cites this paper
• Single-cell and spatial transcriptome profiling reveal CTHRC1+ fibroblasts promote EMT through WNT5A signaling in colorectal cancer

  2025cites this paper
• Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma

  2025cites this paper
• Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer.

  2025cites this paper
• Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis.

  2025cites this paper
• Biomimetic Nanoparticles: A Revolutionary Approach to Breast Cancer Therapy Using Cell Membrane Coatings

  2025cites this paper
• Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis

  2025influential citation
• Clinical comprehensive evaluation of [18F]AlF-FAP-NUR PET: multi-time-point imaging, head-to-head comparison with [18F]FDG

  2025cites this paper
• Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming

  2025cites this paper
• Development and validation of a disulfidptosis-related prognostic model for colorectal cancer using multi-omics analysis

  2025cites this paper
• Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy

  2025cites this paper
• Spatial Regulation of Cancer-Associated Fibroblasts and Tumor Cells via pH-Responsive Bispecific Antibody Delivery for Enhanced Chemo-Immunotherapy Synergy.

  2025cites this paper
• Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts

  2025cites this paper
• Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment

  2025cites this paper
• The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge

  2025cites this paper
• Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

  2025cites this paper
• The role and function validation of P2RX4 as a novel cancer biomarker in pan-cancer analysis

  2025cites this paper
• Cancer-associated fibroblasts in breast cancer in the single-cell era: Opportunities and challenges.

  2025cites this paper